Australian National Enterovirus Reference Laboratory annual report, 2017
DOI:
https://doi.org/10.33321/cdi.2020.44.32Keywords:
poliovirus, acute flaccid paralysis, surveillance, enterovirus, poliomyelitis, eradication, vaccinationAbstract
Australia monitors its polio-free status by conducting surveillance for cases of acute flaccid paralysis (AFP) in children less than 15 years of age, as recommended by the World Health Organization (WHO). Cases of AFP in children are notified to the Australian Paediatric Surveillance Unit or the Paediatric Active Enhanced Disease Surveillance System and faecal specimens are referred for virological investigation to the National Enterovirus Reference Laboratory. In 2017, no cases of poliomyelitis were reported from clinical surveillance and Australia reported 1.33 non-polio AFP cases per 100,000 children, meeting the WHO performance criterion for a sensitive surveillance system. Three non-polio enteroviruses, coxsackievirus B1, echovirus 11 and enterovirus A71, were identified from clinical specimens collected from AFP cases. Australia established enterovirus and environmental surveillance systems to complement the clinical system focussed on children and an ambiguous vaccine-derived poliovirus type 2 was isolated from sewage in Melbourne. In 2017, 22 cases of wild polio were reported with three countries remaining endemic: Afghanistan, Nigeria and Pakistan.
Downloads
References
Australian Paediatric Surveillance Unit (APSU). Study Protocol, Acute Flaccid Paralysis. [Internet.] APSU, 2014. [Accessed: 28 March 2018.] Available from: http://www.apsu.org.au/assets/current-studies/AFP-Study-Protocol-June-2014.pdf
McRae J, Quinn HE, McCartney K. Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2015: prospective hospital-based surveillance for serious paediatric conditions. Commun Dis Intell Q Rep. 2017;41(3):E280–8.
Midgley CM, Jackson MA, Selvarangan R, Turabelidze G, Obringer E, Johnson D et al. Severe respiratory illness associated with enterovirus D68 – Missouri and Illinois, 2014. MMWR Morb Mortal Wkly Rep. 2014;63(36):798–9.
Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778–90.
World Health Organization (WHO). Global wild poliovirus 2013-2018. [Intenet.] WHO, 2018. [Accessed: 28 March 2018.] Available from: http://polioeradication.org/wp-content/uploads/2018/03/global-wild-poliovirus-2013-2018-20180320.pdf
Nnadi C, Damisa E, Esapa L, Braka F, Waziri N, Siddique A et al. Continued endemic wild poliovirus transmission in security compromised areas — Nigeria, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(7):190–3.
World Health Organization (WHO). Global eradication of wild poliovirus type 2 declared. [Internet.] WHO, 2015. [Accessed: 28 March 2018.] Available from: http://www.polioeradication.org/mediaroom/newsstories/Global-eradication-of-wild-poliovirus-type-2-declared/tabid/526/news/1289/Default.aspx
Alleman MM, Chitale R, Burns CC, Iber J, Dybdahl-Sissoko N, Chen Q et al. Vaccine-derived poliovirus outbreaks and events — three provinces, Democratic Republic of the Congo, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(10):300–5.
Previsani N, Singh H, St. Pierre J, Boualam L, Fournier-Caruana J, Sutter RW et al. Progress toward containment of poliovirus type 2 — worldwide, 2017. MMWR Morb Mortal Wkly Rep. 2017;66(24):649–52.
World Health Organization (WHO). Circulating vaccine-derived poliovirus. [Internet.] WHO, 2018. [Accessed: 28 March 2018.] Available from: http://polioeradication.org/polio-today/polio-now/this-week/circulating-vaccine-derived-poliovirus/
World Health Organization (WHO). Fifteenth meeting of the Emergency Committee under the International Health Regulations (2005) regarding the international spread of poliovirus. [Internet.] WHO, 2017. [Accessed: 28 March 2018.] Available from: http://www.who.int/mediacentre/news/statements/2017/ihr-emergency-committee-polio/en/
Department of Health. Poliovirus infection. [Internet.] Australian Government, Department of Health, 2015. [Accessed: 28 March 2018.] Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_polio.htm
World Health Organization (WHO). Poliomyelitis. In WHO-recommended standards for surveillance of selected vaccine-preventable diseases. (WHO/V&B/03.01) Geneva: WHO, Department of Vaccines and Biologicals, 2003.
Wood DJ, Hull B. L20B cells simplify culture of polioviruses from clinical samples. J Med Virol. 1999;58(2):188–92.
World Health Organization (WHO). Polio Laboratory Manual, 4th edition. (WHO/IVB/04.10) Geneva: WHO, Department of Immunization, Vaccines and Biologicals, 2004.
Kilpatrick DR, Yang CF, Ching K, Vincent A, Iber J, Campagnoli R et al. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol. 2009;47(6):1939–41.
Stewardson AJ, Roberts JA, Beckett CL, Prime HT, Loh PS, Thorley BR et al. An imported case of poliomyelitis in Melbourne, Australia. Emerg Infect Dis. 2009;15(1):63–5.
World Health Organization (WHO). Guidelines for environmental surveillance of poliovirus circulation. (WHO/V&B/03.03) Geneva: WHO, Department of Vaccines and Biologicals, 2003.
Roberts, JA. Thesis. “Chapter 2: Development of a Novel Enterovirus Detection and Super-Speciation Assay”, An integrated bioinformatics and computational biophysics approach to enterovirus surveillance and research. RMIT University, 2014: 62-109. [Accessed: 27 March 2018.] Available from: https://researchbank.rmit.edu.au/view/rmit:162129
Cowger TL, Burns CC, Sharif S, Gary HE, Iber J, Henderson E et al. The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan – 2011–2013. PLoS ONE. 2017;12(7): e0180608.
World Health Organization (WHO). Polio environmental surveillance expansion plan. Geneva: WHO, 2015.
Lewis I, Ottosen A, Rubin J, Blanc DC, Zipursky S, Wootton E. A supply and demand management perspective on the accelerated global introductions of inactivated poliovirus vaccine in a constrained supply market. J Infect Dis. 2017:216 (Suppl 1);S33–39.
Published
How to Cite
License
Copyright (c) 2023 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
